glp-1 agonists and sglt2 inhibitors combination Full article: inhibitor receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes Practical Considerations and Rationale for

While glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated systemic anti-inflammatory and vascular benefits beyond glycemic control, their potential impact on tear film parameters remains largely unexplored

doi: 10.1016/s0140-6736(06)69705-5

People in the thread share their personal experiences with Ozempic, emphasizing its effectiveness in managing type 2 diabetes and promoting weight loss

the results showed the efficacy of this drug on body weight, as compared with placebo, although an increase in non-severe gastrointestinal adverse events was also observed [127]

Growth of the regional market will be driven by increase in expenditure on health care by employers and cardiovascular indications

How are you selecting your patients